Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Mie Nieda"'
Publikováno v:
Biomedicines, Vol 10, Iss 5, p 1002 (2022)
Coronavirus disease 2019 (COVID-19) can manifest as acute respiratory distress syndrome and is associated with substantial morbidity and mortality. Extensive data now indicate that immune responses to SARS-CoV-2 infection determine the COVID-19 disea
Externí odkaz:
https://doaj.org/article/bc5d1173e94148afbc2874384bd4b5bc
Publikováno v:
Biomedicines, Vol 9, Iss 5, p 557 (2021)
Natural killer (NK) cells are cytotoxic immune cells with an innate capacity for eliminating cancer cells and virus- infected cells. NK cells are critical effector cells in the immunosurveillance of cancer and viral infections. Patients with low NK c
Externí odkaz:
https://doaj.org/article/060214031ec547f8931c22280af9c2b4
Purpose: Human Vα24+Vβ11+ natural killer T-cells (NKT cells) have antitumor activity via direct cytotoxicity and by induction of antitumor actions of T and NK cells. Activation of NKT cells is crucial for their antitumor activity and is induced by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b209d76bd636ff0c1c3f92c6ccefa9c
https://doi.org/10.1158/1078-0432.c.6519657.v1
https://doi.org/10.1158/1078-0432.c.6519657.v1
Publikováno v:
Clinical and Experimental Immunology. 194:54-66
Summary The finding that dendritic cells (DCs) orchestrate innate and adaptive immune responses has stimulated research on harnessing DCs for developing more effective vaccines for DC therapy. The expression of cytomegalovirus (CMV) antigens in gliob
Publikováno v:
International Immunopharmacology. 22:486-491
Adoptive immunotherapy of cancer is evolving with the development of novel technologies for generating a large number of activated killer cells such as natural killer (NK) cells, γδ T cells, and αβ T cells. We have recently established large-scal
Autor:
Mie Nieda, Toshiaki Yoshikawa, Mai Tomiyama, Ryuji Maekawa, Tetsuya Nakatsura, Masashi Takahara
Publikováno v:
International Journal of Oncology
Specific cellular immunotherapy for cancer requires efficient generation and expansion of cytotoxic T lymphocytes (CTLs) that recognize tumor-associated antigens. However, it is difficult to isolate and expand functionally active T-cells ex vivo. In